GPEA · FR0014017NX3 · class UCITS ETF Acc · EUR · domicile France
Equity · GlobalSFDR art. 6
Index tracked: MSCI AC World Index Daily Net TR EUR
TER
0.30%+ trans. 0.00%
Fund size
52 m EUR
Tracking difference
—not computable
🇮🇹 tax rate
26.00%equity
Replication
Synthetic (swap)
Income
Accumulating
Launch 6 Jul 2026 · costs from the KID as of 2 Sept 2026 · 50 securities held · 3 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Fund is a passively managed index-based UCITS. The Fund's management objective is to replicate, both upwards and downwards, the performance of the MSCI ACWI Index (EUR) (net dividends reinvested) (the "Benchmark"), denominated in euro and representative of the performance of large- and mid-cap companies listed on developed and emerging markets, while minimising the tracking error between the Fund's performance and that of the Benchmark. The expected level of the tracking error under normal market conditions is indicated in the Fund prospectus. More…
Performance since series start (in euro) — base 100
6 Jul 2026 → 8 Sept 2026 · dividends reinvested where declared by the issuer
High 102 (13 Aug 2026) · low 97 (29 Jul 2026) · last 100. Past performance is not indicative of future results.
RebalixGPEA · FR0014017NX3 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: index series not published by the issuer
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 19 Aug 2026 · 50 securities · top-10 weight = 52.0%
The live sheet, always up to date rebalix.com/en/etf/FR0014017NX3 Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.